33.21
0.21%
0.07
Apellis Pharmaceuticals Inc (APLS) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
17.73%
172.32
|
146.38 | 110.40 | 94.97 | 44.85 |
Operating Expenses
|
1.52%
234.41
|
230.90 | 247.48 | 215.41 | 219.93 |
Benefits Costs and Expenses |
2.16%
238.58
|
233.53 | 250.40 | 216.81 | 222.34 |
Costs And Expenses |
2.16%
238.58
|
233.53 | 250.40 | 216.81 | 222.34 |
Operating Income/Loss |
26.54%
-62.09
|
-84.52 | -137.08 | -120.44 | -175.08 |
Income/Loss From Continuing Operations Before Tax |
23.98%
-66.25
|
-87.15 | -140.00 | -121.84 | -177.50 |
Income Tax Expense/Benefit |
88.05%
0.17
|
1.423 | 0.233 | 0.194 | 0.282 |
Income/Loss From Continuing Operations After Tax |
25.01%
-66.42
|
-88.58 | -140.24 | -122.04 | -177.78 |
Net Income/Loss
|
25.01%
-66.42
|
-88.58 | -140.24 | -122.04 | -177.78 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
99.90%
0.123
|
118.56 | 0.1203 | 0.1193 | 0.1139 |
Diluted Average Shares |
99.90%
0.123
|
118.56 | 0.1203 | 0.1193 | 0.1139 |
Basic Earnings Per Share |
25.00%
-0.54
|
-0.72 | -1.17 | -1.02 | -1.56 |
Diluted Earnings Per Share |
25.00%
-0.54
|
-0.72 | -1.17 | -1.02 | -1.56 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):